IPP Bureau
Lupin inks US licensing deal with Valorum for biosimilar Armlupeg
By IPP Bureau - December 05, 2025
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Medtronic and Symbiosis International inaugurate center for advanced surgical, cadaver-based training
By IPP Bureau - December 05, 2025
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Granules’ packaging facility in US completes FDA inspection with zero observations
By IPP Bureau - December 05, 2025
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Fortis ropes in 'Yamraj' to launch nationwide helmet safety drive
By IPP Bureau - December 05, 2025
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Briefs: Sun Pharma and Venus Remedies
By IPP Bureau - December 04, 2025
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
Kytopen & TQ Therapeutics forge partnership to advance next-generation cell therapies
By IPP Bureau - December 04, 2025
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
Wellcome injects £2 million to turbocharge UK regulation of digital mental health tech
By IPP Bureau - December 04, 2025
Stratasys completes US rollout of RadioMatrix 3D-printed imaging support material
By IPP Bureau - December 04, 2025
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
Philips unveils helium-free 3.0T MRI innovation at RSNA 2025
By IPP Bureau - December 04, 2025
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Zuellig Pharma launches advanced clinical trial facility in South Korea
By IPP Bureau - December 04, 2025
Jacobio combo delivers 71% ORR, sets stage for first SHP-2–based NSCLC therapy
By IPP Bureau - December 04, 2025
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
Aptar acquires Brazilian pharma packaging firm Sommaplast
By IPP Bureau - December 04, 2025
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Aelis Farma gets EMA nod for phase 2B trial of AEF0217 in down syndrome
By IPP Bureau - December 04, 2025
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
ZIM Laboratories receives CDSCO approval for Naproxen + Esomeprazole capsules
By IPP Bureau - December 04, 2025
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
Jubilant Pharmova appoints Daniel J. O Connor as CEO of Jubilant Therapeutics
By IPP Bureau - December 04, 2025
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
